The historical rank and industry rank for Carna Biosciences's Days Inventory or its related term are showing as below:
TSE:4572'
s Days Inventory Range Over the Past 10 Years
Min: 166.52 Med: 220.19 Max: 667.18
Current: 667.18
During the past 13 years, Carna Biosciences's highest Days Inventory was 667.18. The lowest was 166.52. And the median was 220.19.
TSE:4572's Days Inventory is ranked worse than 86.32% of 636
companies
in the Biotechnology industry
Industry Median: 183.195
vs TSE:4572: 667.18
Carna Biosciences's Days Inventory
stayed the same
from Dec. 2024 (0.00) to Dec. 2025 (0.00).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Carna Biosciences's Inventory Turnover for the
three
months ended in Dec. 2025 was 0.00.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Carna Biosciences (TSE:4572) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Carna Biosciences's Inventory Turnover for the
three
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Carna Biosciences's Inventory to Revenue for the
three
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Carna Biosciences Days Inventory Related Terms
Carna Biosciences Days Inventory Historical Data
* Premium members only.
The historical data trend for Carna Biosciences's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4572 vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Carna Biosciences's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Carna Biosciences Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Carna Biosciences's Days Inventory distribution charts can be found below:
* The bar in red indicates where Carna Biosciences's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Carna Biosciences (TSE:4572) has a Days Inventory of 0.00 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Carna Biosciences and its competitors. Over the past decade, Carna Biosciences' Days Inventory has ranged from 166.52 to 667.18. According to the industry distribution chart, Carna Biosciences ranks #549 out of 636 companies in the Biotechnology industry, placing it in the top 86.3%.
Is Carna Biosciences' Days Inventory too high?
Carna Biosciences' current Days Inventory is 0.00. Over the past 10 years, this metric has ranged from a low of 166.52 to a high of 667.18. Based on the distribution chart, Carna Biosciences ranks #549 out of 636 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Carna Biosciences has a GF Score™ of 34/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Carna Biosciences' Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Carna Biosciences ranks #549 out of 636 companies for Days Inventory. This places Carna Biosciences in the lower half of its industry. The industry median Days Inventory is 183.20. Historically, Carna Biosciences' own Days Inventory has ranged from 166.52 to 667.18 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 636 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Carna Biosciences and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Carna Biosciences's current Days Inventory is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carna Biosciences stock overvalued right now?
Based on GuruFocus' analysis, Carna Biosciences (TSE:4572) is currently considered Significantly Overvalued. The stock's GF Value™ is 円188.38, compared to a current price of 円348.00 — trading 84.7% above its estimated fair value. The current Days Inventory is 0.00. Carna Biosciences' overall GF Score™ is 34/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Carna Biosciences (TSE:4572), the current Days Inventory is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Carna Biosciences (TSE:4572) Overvalued in 2026?
Based on GuruFocus' analysis, Carna Biosciences stock appears to be overvalued.
The current stock price of 円348.00 is trading 84.7% above its estimated GF Value™ of 円188.38.
GuruFocus considers Carna Biosciences to be Significantly Overvalued.
Key valuation signals for TSE:4572:
Days Inventory: 0.00
GF Value™: 円188.38 vs. price of 円348.00 (84.7% above fair value)
No single metric tells the full story. See the TSE:4572 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Carna Biosciences Inc is a Japanese company engaged in drug discovery support business and drug discovery and development business. The company identifies and develops medicines for the treatment of cancer and inflammatory diseases using own kinase drug discovery platform, QuickScout.
34GF Score
Get the complete analysis for TSE:4572
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4572 has been successfully added to your 
